- Home
- GLMD vs SCNI Comparison
GLMD vs SCNI Comparison
Compare GLMD & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- SCNI
- Stock Information
- Founded
- GLMD 2000
- SCNI 2003
- Country
- GLMD Israel
- SCNI Israel
- Employees
- GLMD N/A
- SCNI N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLMD Health Care
- SCNI Health Care
- Exchange
- GLMD Nasdaq
- SCNI Nasdaq
- Market Cap
- GLMD 3.0M
- SCNI 3.2M
- IPO Year
- GLMD 2014
- SCNI N/A
- Fundamental
- Price
- GLMD $1.83
- SCNI $2.20
- Analyst Decision
- GLMD Hold
- SCNI
- Analyst Count
- GLMD 1
- SCNI 0
- Target Price
- GLMD N/A
- SCNI N/A
- AVG Volume (30 Days)
- GLMD 353.4K
- SCNI 1.1M
- Earning Date
- GLMD 05-22-2025
- SCNI 08-14-2025
- Dividend Yield
- GLMD N/A
- SCNI N/A
- EPS Growth
- GLMD N/A
- SCNI N/A
- EPS
- GLMD N/A
- SCNI N/A
- Revenue
- GLMD N/A
- SCNI $658,000.00
- Revenue This Year
- GLMD N/A
- SCNI N/A
- Revenue Next Year
- GLMD N/A
- SCNI N/A
- P/E Ratio
- GLMD N/A
- SCNI N/A
- Revenue Growth
- GLMD N/A
- SCNI N/A
- 52 Week Low
- GLMD $1.15
- SCNI $1.90
- 52 Week High
- GLMD $23.80
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- GLMD 60.37
- SCNI 42.95
- Support Level
- GLMD $1.74
- SCNI $2.12
- Resistance Level
- GLMD $1.91
- SCNI $2.85
- Average True Range (ATR)
- GLMD 0.12
- SCNI 0.20
- MACD
- GLMD -0.00
- SCNI 0.00
- Stochastic Oscillator
- GLMD 71.95
- SCNI 11.37
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.